Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-26 @ 3:18 AM
NCT ID:
NCT04326920
Group ID:
EG000
Title:
Active Sargramostim Treatment Group
Description:
Inhaled sargramostim 125mcg twice daily for 5 days on top of standard of care. Upon progression to ARDS and initiation of mechanical ventilator support within the 5 day period, inhaled sargramostim will be replaced by intravenous sargramostim 125mcg/m2 body surface area once daily until the 5 day period is reached. From day 6 onwards, progressive patients in the active group will have the option to receive an additional 5 days of IV sargramostim, based on the treating physician's assessment
Sargramostim: Inhalation via mesh nebulizer and/or IV administration upon Clinical deterioration
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
40
Other Number Affected:
22
Other Number At Risk:
40
Study:
NCT04326920
Results Section:
NCT04326920
Adverse Events Module:
NCT04326920